Do We Use Methylation of <i>NFATC1</i> and <i>FOS</i> Genes As a Biomarker for Postmenopausal Osteoporosis?

Kalkan, R; Tosun, O

Do We Use Methylation of NFATC1 and FOS Genes As a Biomarker for Postmenopausal Osteoporosis?

Kalkan, R; Tosun, O.

Afiliación

Kalkan R; Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Cyprus.
Tosun O; Department of Biostatistics, Faculty of Medicine, Near East University, Nicosia, Cyprus.

Balkan J Med Genet ; 23(2): 35-40, 2020 Nov.

Article en En | MEDLINE | ID: mdl-33816070

Palabras clave

FOS; Methylation; Methylation sensitive-high resolution melting (MS-HRM); NFATC1; Postmenopause; Premenopause

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009562
https://dx.doi.org/10.2478/bjmg-2020-0021

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009562
https://dx.doi.org/10.2478/bjmg-2020-0021

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article